Myo‐inositol‐1‐phosphate (MIP) synthase: a possible new target for antibipolar drugs
The DOI matches its Crossref record.
Abstract
Agam G, Shamir A, Shaltiel G, Greenberg ML. Myo‐inositol‐1‐phosphate (MIP) synthase: a possible new target for antibipolar drugs. Bipolar Disord 2002: 4(Suppl. 1): 15–20. © Blackwell Munksgaard, 2002 Inositol metabolism is well characterized in yeast at a molecular level, and yeast is the only eukaryote in which genetic, molecular and functional genomic approaches to identify lithium, valproate and inositol targets may be combined readily. It has been shown that lithium inhibits yeast inositol monophosphatase (encoded by INM1 and INM2), and both valproate and lithium reduce intracellularinositol. Unlike lithium, valproate causes a decrease in intracellular inositol‐1‐phosphate as well, suggesting that myo‐inositol‐1‐P (MIP) synthase is a site of valproate action in the yeast PI cycle. MIP synthase is the rate‐limiting step in inositol biosynthesis and is highly regulated in response to inositol. Yeast genes that are affected by both lithium and valproate in the phosphoinositide pathways (INO1 increased over 10‐fold, INO2 increased twofold and INM1 decreased about twofold) have been identified. It has also been reported previously that both lithium and inositol mildly up‐regulate IMPA1 (encoding mammalian inositol monophosphatase) expression in human cells. These findings indicate that IMPA is regulated only mildly by lithium, and therefore may not be the major target in the inositol pathway. Given the substantial evidence for the role of inositol in the mechanism of action of lithium and valproate,the opposing and mild effects of lithium on the genes encoding inositol monophosphatase in yeast and human cells, but the powerful effect of lithium and valproate on INO1 in yeast, it is hypothesized that human hINO1 is a factor in the psychopharmacology of mood stabilizers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Geddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia
Berridge, M. J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1806-z · Cited by 181
“First, it may act to inhibit the inositol synthase responsible for the de novo synthesis of inositol from glucose- 6-phosphate (Agam et al. 2002; Shaltiel et al. 2004).”
BackgroundLithium: the pharmacodynamic actions of the amazing ion
Brown, K. M., & Tracy, D. K. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312471963 · Cited by 140
“The mechanism by which lithium exerts its effects on the PI signalling pathway is still unclear, and it remains possible, for example, that a decrease in intracellular myoinositol is only the first stage of action, initiating a cascade of secondary changes in the PKC signalling pathway and gene expression [Agam et al.…”
BackgroundKnockout mice in understanding the mechanism of action of lithium
Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., & Belmaker, R. H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371121 · Cited by 50
Self-citation
Metadata
- Authors
- Agam, G., Shamir, A., Shaltiel, G., & Greenberg, M. L.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2002-09
- Volume
- 4
- Issue
- s1
- Pages
- 15-20
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W2075177277
- Cited by
- 45
- References
- 0
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myo‐inositol‐1‐phosphate (MIP) synthase: a possible new target for antibipolar drugs. https://app.cochat.ai/papers/10.1034/j.1399-5618.4.s1.2.x
- The paper
- Agam, G., Shamir, A., Shaltiel, G., & Greenberg, M. L. (2002). Myo‐inositol‐1‐phosphate (MIP) synthase: a possible new target for antibipolar drugs. Bipolar Disorders. https://doi.org/10.1034/j.1399-5618.4.s1.2.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.